Arctic Sun Neonatal ArcticGel Pad
Medivance, Inc. · Decision date Oct 30, 2026
What did the FDA decide?
Medivance, Inc. received a substantially equivalent (SESE) decision for the Arctic Sun™ Neonatal ArcticGel™ Pad, 510(k) number K263587, on 30 October 2026. The FDA record lists the device under classification name System, Thermal Regulating, regulation number 870.5900, product code DWJ, with a Cardiovascular medical specialty and Cardiovascular review panel. The application was received on 30 September 2026.
The record identifies the cleared item as the neonatal ArcticGel pad, a component of the Arctic Sun thermal regulating system rather than a standalone new system. The decision is a 510(k) clearance, not a premarket approval. The page notes a Special summary, no third-party review, no combination product status and no authorized predetermined change control plan. The source does not describe materials, dimensions, temperature performance or the predicate device, so those details remain unknown here.
The public record does not state indications for use, patient-selection criteria or treatment parameters; those belong to the original FDA documentation and were not available in this source.
- Regulatory pathway
- 510(k) premarket notification
- Clinical specialty
- Cardiovascular
- Decision date
- Oct 30, 2026
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- K263587
- Regulatory pathway
- 510(k) premarket notification
- Applicant
- Medivance, Inc.
- Product code
- DWJ
- Decision code
- SESE
- Decision date
- Oct 30, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: System, Thermal Regulating.
- Applicant
- Medivance, Inc.
- Product code
- DWJ
- FDA device class
- 2
FDA decision timeline
K263587 received
Application receipt date recorded by FDA.
K263587 · FDA decision
SESE
Related devices and submissions
Explore the linked device profile
No additional submissions with a verified PMA or product-code relationship are linked here.
Regulatory context
A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Medivance, Inc.
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- Louisville, CO
Sources and methodology
- Original FDA record: K263587
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records